Long-term survival of a cohort of patients with heart failure: Perspective from the real world

Abstract Introduction Heart failure (HF) is the leading cause of hospitalization in Spain over 65 years of age, with a large morbidity and mortality problem and costs. The objective of this work is to evaluate the 15-year survival of the EPICOUR study cohort and analyze the variability of the risk f...

Full description

Saved in:
Bibliographic Details
Published inEuropean geriatric medicine Vol. 8; no. 4; pp. 304 - 309
Main Authors Mouriño López, V.M, Cid Conde, L, Alves Pérez, M.T, López Castro, J
Format Journal Article
LanguageEnglish
Published Elsevier Masson SAS 01.09.2017
Subjects
Ejection fraction
Exitus
Heart failure
Internal Medicine
Prognosis
Survival
Heart failure
Prognosis
Survival
Exitus
Ejection fraction
Online AccessGet full text

Cover

More Information
Summary:Abstract Introduction Heart failure (HF) is the leading cause of hospitalization in Spain over 65 years of age, with a large morbidity and mortality problem and costs. The objective of this work is to evaluate the 15-year survival of the EPICOUR study cohort and analyze the variability of the risk factors of mortality according to age and progression of HF. Material and methods Prospective observational study of a cohort of 384 patients with follow-up at 15 years. Results The mean age was 74.84 (± 11.0) years. 53.4% were men and almost 75% belonged to rural areas. 305 patients (82.4%) were exitus against 65 (17.6%); in 14 cases, it was not possible to carry out a follow-up. The factors associated with a higher mortality risk were the age and diagnosis of ischemic heart disease, high blood pressure (HBP), diabetes mellitus, chronic obstructive pulmonary disease, acute myocardial infarction, valvulopathy, peripheral arteriopathy, and intraventricular and high-degree atrioventricular block (Mobitz 2nd and 3rd degree). The drugs with protective effect were anticoagulants and beta-blockers. The probability of survival was 77.6% the first year, 42.4% at 5 years, 24.3% at 10 years, and 16.7% at 15 years of follow-up. Conclusion Mortality due to HF was high (82.4%), although there are hardly any references in the literature that allow us to make such long-term comparisons (15 years). Reduced ejection fraction is a powerful predictor of long-term mortality, especially after the 6th year.
ISSN:1878-7649
1878-7657
DOI:10.1016/j.eurger.2017.04.010